Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Carcinoma, Non-Small-Cell Lung 199Breast Neoplasms 136Prostatic Neoplasms 73Neoplasms 62Neoplasm Metastasis 52Lung Neoplasms 45Stomach Neoplasms 27Parkinson Disease 4, Autosomal Dominant Lewy Body 22Squamous Cell Carcinoma of Head and Neck 17Ovarian Neoplasms 15Advanced Solid Tumors 14Recurrence 12Head and Neck Neoplasms 11Colorectal Neoplasms 11Carcinoma, Squamous Cell 11Urinary Bladder Neoplasms 10Melanoma 10Esophageal Neoplasms 10HER2-positive Breast Cancer 9Endometrial Neoplasms 9Carcinoma, Renal Cell 9Sarcoma 8Esophageal Squamous Cell Carcinoma 8Carcinoma, Transitional Cell 8Solid Tumor 7Prostatic Neoplasms, Castration-Resistant 7Pancreatic Neoplasms 7Carcinoma 7Triple Negative Breast Neoplasms 6Small Cell Lung Carcinoma 6

Interventions

Gemcitabine 6Cisplatin 6pembrolizumab 4Docetaxel 4Capecitabine 4Oxaliplatin 2Carboplatin 2toripalimab 1tocilizumab 1tislelizumab 1spartalizumab 1cc-486 1Injections 1Fluorouracil 1Dexamethasone 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Nasopharyngeal Neoplasms × Docetaxel × Clear all
NCT06892431 2025-03-25

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Shanghai JMT-Bio Inc.

Phase 2 Not yet recruiting
150 enrolled
Head & Neck

Nasopharyngeal Neoplasms, Recurrence

NCT02611960 2023-07-13

Keynote-122

Merck Sharp & Dohme LLC

Phase 3 Completed
233 enrolled 21 charts
Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Nasopharyngeal Neoplasms

NCT00565448 2015-07-30

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Sanofi

Phase 2 Completed
75 enrolled 10 charts
Head & Neck

Nasopharyngeal Carcinoma, Carcinoma, Nasopharyngeal Neoplasms

NCT00436293 2010-11-17

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

Sanofi

Phase 2 Completed
61 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡